ALKEM LABORATORIES at All Time High; BSE HEALTHCARE Index Down 1.4%
September 24, 2021 01:48 PM

ALKEM LABORATORIES share price has hit an all-time high at Rs 4,068 (up 1.7%).

Meanwhile, the BSE HEALTHCARE Index is at 26,720 (down 1.4%).

Among the top gainers in the BSE HEALTHCARE Index today are ALKEM LABORATORIES (up 1.7%) and PROCTER & GAMBLE HEALTH (up 0.3%).

SUN PHARMA ADV. RES. and BLISS GVS PHARMA (down 0.1%) are among the top losers today.

Over the last one year, ALKEM LABORATORIES has moved up from Rs 2,803 to Rs 4,068, registering a gain of Rs 1,265 (up 43.8%).

The BSE HEALTHCARE has moved up from 19,615 to 26,720, registering a gain of 7,105 points (up 33.6%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were APOLLO HOSPITALS (up 165.8%), PIRAMAL ENTERPRISES (up 119.9%) and LAURUS LABS (up 115.1%).

What About the Benchmark Indices?

The BSE Sensex is at 60,333 (up 0.2%). The top gainers among the BSE Sensex stocks today are ASIAN PAINTS (up 3.8%), HCL TECHNOLOGIES (up 2.8%) and BHARTI AIRTEL (up 1.9%). Other gainers include M&M (up 1.8%) and INFOSYS (up 1.6%). The most traded stocks in the BSE Sensex are BHARTI AIRTEL and HDFC BANK.

In the meantime, NSE Nifty is at 17,948 (up 0.1%). The top gainers in the NSE Nifty include ASIAN PAINTS (up 3.9%), HCL TECHNOLOGIES (up 2.8%) and BHARTI AIRTEL (up 1.8%). Other gainers include M&M (up 1.8%) and GRASIM (up 1.7%).

Over the last 12 months, the BSE Sensex has moved up from 37,734 to 60,333, registering a gain of 22,599 points (up 59.0%).

ALKEM LABORATORIES Financial Update...

ALKEM LABORATORIES net profit stood at Rs 5 billion for the quarter ended June 2021, compared to a profit of Rs 5 billion a year ago. Net Sales rose 17.8% to Rs 27.3 billion during the period as against Rs 23.2 billion in April-June 2020.

For the year ended March 2021, ALKEM LABORATORIES reported 40.8% increase in net profit to Rs 16.2 billion compared to net profit of Rs 11.5 billion during FY20.

Revenue of the company grew 6.2% to Rs 89 billion during FY21.

The current Price to earnings ratio of ALKEM LABORATORIES, based on rolling 12 month earnings, stands at 28.8x.